Limaye, S., Patil, D., Akolkar, D., Srivastava, N., Patil, R., Apurwa, S., . . . Datar, R. (2021). Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma. Wiley.
Cita Chicago Style (17a ed.)Limaye, Sewanti, et al. Response to Pazopanib‐based Combination Regimen in a Case of FGFR3 Amplified Gastric Adenocarcinoma. Wiley, 2021.
Cita MLA (8a ed.)Limaye, Sewanti, et al. Response to Pazopanib‐based Combination Regimen in a Case of FGFR3 Amplified Gastric Adenocarcinoma. Wiley, 2021.
Precaución: Estas citas no son 100% exactas.